By Organization Size

Mid-Market Biotech / CRO (50–10,000 employees) Market Analysis

Cross-industry research covering Mid-Market Biotech / CRO (50–10,000 employees) across 1 market reportspanning ICT / Life Sciences Software.

1 Reports

1 Industries

Reports Covering Mid-Market Biotech / CRO (50–10,000 employees)

Molecular Biology Simulation Software Market to Reach USD 1.8B by 2033 at 9.2% CAGR

ICT / Life Sciences Software·Market: USD 0.87 Billion (2025)·CAGR: 9.2%

Series-B-through-public-stage biotechs and mid-market CROs represent the fastest-growing enterprise buyer cohort by logo count, driven by VC-funded drug discovery programmes that require computational infrastructure without the headcount to manage on-premises HPC. Cloud-native and PLG-accessible tools with transparent consumption pricing have the highest win rates here.

27%

Market Share

10.1%

Segment CAGR

Explore More Segments

Browse all market segments across our research coverage.

View all segments